New Releases from NCBI BookshelfTofersen (Qalsody): Indication: For the treatment of adults with amyotrophic lateral sclerosis associated with a mutation in the superoxide dismutase 1 gene: Reimbursement Recommendation [Internet].​Tofersen (Qalsody): Indication: For the treatment of adults with amyotrophic lateral sclerosis associated with a mutation in the superoxide dismutase 1 gene: Reimbursement Recommendation [Internet].